Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Angle Plc LSE:AGL London Ordinary Share GB0034330679 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.00 -2.92% 66.50 65.00 68.00 68.50 66.50 68.50 201,651 15:09:32
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.7 -10.9 -6.6 - 115

Angle Share Discussion Threads

Showing 51651 to 51674 of 51675 messages
Chat Pages: 2067  2066  2065  2064  2063  2062  2061  2060  2059  2058  2057  2056  Older
DateSubjectAuthorDiscuss
05/6/2020
20:12
Thanks Alan.
fhmktg
05/6/2020
16:57
The process of recruitment of volunteers etc. will be specified in the protocol forming part of the FDA submission. Angle can't just alter the process if it happens to suit.
alanrussell
05/6/2020
16:35
Three weeks to results day and I am sure the analysts will ask some pretty angry questions if there is no progress by then.Why on Earth they can't get volunteers through their US or Canadian set up, I don't know.
fhmktg
05/6/2020
15:41
Disappointing end to the week. Hoping the required blood tests have been given the green light to go ahead and Angle will be able to obtain the volunteers.
maxie23
02/6/2020
11:20
Recently it picks up in afternoon too so fingers crossed that continues
iroquoi
02/6/2020
11:12
Some weighty buys coming through today...
candlestick1
01/6/2020
12:13
Anybody been in touch to find out any progress on blood samples?
fhmktg
31/5/2020
18:57
Perhaps Angle should contact the publisher and tell them what a really useful blood test can do for diagnosis and treatment !!!!!
millwallfan
31/5/2020
15:05
Thanks Clausentum - assumed it wasn’t - the bits I have read are vague as usual.
semper vigilans
31/5/2020
14:11
The prostate cancer study measured ctDNA, and therefore could not involve Parsortix, which collects whole viable cancer cells, not bits of DNA.
clausentum
31/5/2020
12:22
Is it a fuller article if you subscribe please? There is a tiny mention on page 11 of the Sunday Times, but is Parsortix involved?
semper vigilans
31/5/2020
07:57
Blood test could spare prostate cancer patients painful biopsies http://digitaleditions.telegraph.co.uk/data/244/reader/reader.html?social#!preferred/0/package/244/pub/244/page/51/article/46812Excellent article today.
fhmktg
29/5/2020
17:29
Surprising end to the day, but more than welcome. Roll on the 70s!
candlestick1
29/5/2020
07:36
The delay to posting the results should enable the Company to complete the fda submission.......hopefully!
fhmktg
28/5/2020
19:33
Am I mistaken or are we about to move NORTH. As I said recently, only to be laughed at by the resident clown. Next stop if the reverse head & shoulders plays out is 88p. It is an if mind, but I suspect it will.
jelenko
27/5/2020
16:49
Must be news soon. By the way Fincap jumped on the bid order this afternoon I'd guess that an RNS tomorrow might be on the cards, I say might. I don't believe the "Chinese Walls" theory at Fincap myself
jelenko
27/5/2020
16:40
5% increase on no formal news release so yes it could be ISA purchases but we are now 8 weeks into new financial year and the price has been a lot lower a few weeks ago. I wonder if things have progressed faster than we believed in relation to the FDA preparations and/or some indication that the FDA will recommence validations soon.
millwallfan
27/5/2020
14:59
look like ISA moves.
jelenko
27/5/2020
14:51
Are these double-up transactions just roll-overs?Looking like a nice rise today, be good to get above 70 before any news comes around submission.
candlestick1
27/5/2020
10:38
Time for some decent news?
semper vigilans
24/5/2020
17:12
Hey SK - agree that timelines are challenging but still think they should be getting the submission sorted pretty quickly once those samples are sorted. As long as they have used the lockdown time wisely re paperwork. Guess it also depends on how many samples are outstanding...
candlestick1
24/5/2020
11:03
Hi candlestick1, I don't see things like you do. I see that the timelines have been moved back and that things will not be almost immediate. Yes, in March they said, "We are therefore completing the full write up of the submission with the aim that within a few weeks of the current government restrictions being relaxed we will be able to reinstate healthy volunteer blood collection, process the final analytical samples and make our FDA submission". By contrast in April they dropped the "few weeks" after lockdown claim and replaced it with the word "promptly". "This is progressing well and it is expected that submission can be made promptly once restrictions ease so that we can secure the remaining healthy volunteer blood samples needed to complete the analytical study work". To me the change from "few weeks" to "promptly" is important. Had the timeline remained a "few weeks" they would have said so. Then we have the emails with Newland that were summarised on here, confirming that things were more complicated than first anticipated, e.g. from Maxie: "There remains a lack of specific, detailed and clear guidance from Government as to how changes relate to our specific circumstances and as a consequence we need to be careful with how we interpret and apply such changes to our operations. We need to take into account Health & Safety guidelines (risk assessments), protecting our staff and the blood donors, compliance with our formal ethics approval for drawing blood, other ethical considerations, insurance matters and legal restrictions. Because of all these factors, it is not possible to give a clear answer to the question of timing as this is a work in progress and not within our control. We are working on our procedures (enhanced hygiene, use of PPE etc) and sources of blood so as to be able to recommence blood donations as soon as possible. The situation is extremely complex with multiple elements under consideration and detailed guidance changing and/or being clarified. It is also unclear, once we do recommence blood donations, how willing or available donors will be to donate and therefore how quickly we will be able to source the blood we require in the necessary quantities for the experiments and from the correct demographic of donors. So the situation remains challenging, but we are doing everything possible from our side"
sicilian_kan
24/5/2020
09:46
I notice that the Lab Services offered by Angle seems to be expanding. hTTps://angleplc.com/angle-ctc-lab-services/overview/ They are now offering (for use in research or trials):- - Enumeration of epithelial and mesenchymal CTCs and CTC clusters - Multiplex gene expression profiling of CTCs - PD-L1 expression analysis of CTCs - Custom CTC assays
miavoce
23/5/2020
16:46
From Jan - *Whilst significant work remains to complete the written submission, which is expected to run to several thousand pages, all of which will be subject to substantive review and questioning by FDA, ANGLE believes that all of the critical issues were addressed in the meeting and that there is now a clear route to full De Novo FDA Submission.*From April - *Following a period of unanticipated disruption and delay caused by COVID-19, a key focus during lock down is on finalising the significant amount of written documentation and analysis for the FDA submission, so that this can be rapidly submitted once the remaining analytical samples are available and analysed. This is progressing well and it is expected that submission can be made promptly once restrictions ease so that we can secure the remaining healthy volunteer blood samples needed to complete the analytical study work.*So the expectation is that the submission will be almost immediate, once the final samples are secured. May not be too far down the line now for a submission, I guess the next RNS on the matter will be post-submission..
candlestick1
Chat Pages: 2067  2066  2065  2064  2063  2062  2061  2060  2059  2058  2057  2056  Older
ADVFN Advertorial
Your Recent History
LSE
AGL
Angle
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200606 21:24:07